# A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses

> **NCT07179003** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Rochester** · enrollment: 50 (estimated)

## Conditions studied

- Breast Abscess

## Interventions

- **PROCEDURE:** Standard of care breast abscess drainage
- **DRUG:** Methylene Blue
- **DRUG:** Lipid Emulsion
- **DEVICE:** Insertion of optical fiber
- **DEVICE:** Laser illumination
- **PROCEDURE:** Photodynamic therapy

## Key facts

- **NCT ID:** NCT07179003
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2031-03
- **Final completion:** 2031-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07179003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07179003, "A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07179003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*